Contact information
Research groups
Thomas Christott
Research Assistant
Thomas Christott graduated with a Diploma in Biology (technologically oriented) from the University of Stuttgart, Germany in 2012. He joined ProImmune, Ltd. in Oxford from 2012 to 2015 as an assay scientist, working with the REVEAL and ProVE T-cell epitope discovery platforms as well as their protein purification pipeline.
In July 2015, he returned to the fold of academia and joined the Screening group at the Target Discovery Institute.
Recent publications
-
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
Journal article
Pouwels KB. et al, (2021), The Lancet Public Health, 6, e30 - e38
-
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Journal article
Ainsworth M. et al, (2020), The Lancet Infectious Diseases, 20, 1390 - 1400
-
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study
Journal article
Eyre DW. et al, (2020), eLife, 9
-
Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1
Journal article
Ni X. et al, (2019), ACS Medicinal Chemistry Letters, 10, 1661 - 1666
-
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function
Journal article
Fagan V. et al, (2019), Journal of Medicinal Chemistry